Clorox Corporation (NYSE:CLX) posted upbeat third-quarter results and updated full-year guidance on Thursday.

Clorox reported third-quarter revenue of $1.67 billion, flat versus the same period year-over-year. Organic sales were down 1% year-over-year in the quarter.

The company’s revenue total beat a Street consensus estimate of $1.667 billion, according to data from Benzinga Pro. Clorox reported third-quarter earnings per share of $1.64, beating a Street consensus estimate of $1.55.

“Our third-quarter results were mixed, with continued momentum in some parts of our portfolio and slower-than-anticipated market share recovery in others,” Clorox CEO Linda Rendle said.

Updated guidance for Clorox calls for net sales to be down 6% year-over-year in fiscal 2026. The company lowered its adjusted earnings per share guidance for the full fiscal year from a previous range of $5.95 to $6.30 to a new range of $5.45 to $5.65. The current Street consensus estimate is $5.89, according to data from Benzinga Pro.

Clorox shares fell 9.7% to close at $87.11 on Friday.

These analysts made changes to their price targets on Clorox following earnings announcement.

  • Evercore ISI Group analyst Javier Escalante maintained the stock with an Underperform rating and lowered the price target from $115 to $110.
  • Wells Fargo analyst Chris Carey maintained the stock with an Equal-Weight rating and cut the price target from $110 to $100.
  • JP Morgan analyst Andrea Teixeira maintained the stock with an Underweight rating and lowered the price target from $99 to $95.
  • Citigroup analyst Filippo Falorni maintained the stock with a Neutral and lowered the price target from $110 to $97.

Considering buying CLX stock? Here’s what analysts think:

Photo via Shutterstock